# Inhibikase (IKT) — Earnings

IKT · NASDAQ · Stock

Canonical page: https://www.lighthorse.io/tickers/ikt/earnings

## Most recent quarter

| Metric | Value |
| --- | --- |
| Fiscal period | Q2 2025 |
| Period end | Jun 30, 2025 |
| EPS actual | −$0.11 |
| EPS estimate | −$0.08 |
| EPS surprise | −37.50% |
| Revenue surprise | +0.00% |
| Revenue | $0.00 |
| Revenue estimate | $0.00 |
| Reported | Aug 14, 2025 |
| SEC filing | [View filing](https://www.sec.gov:443/Archives/edgar/data/1750149/000119312525180899/ikt-20250630.htm) |

## Earnings history

| Fiscal period | Report date | EPS estimate | EPS actual | Surprise | Revenue estimate | Revenue actual |
| --- | --- | --- | --- | --- | --- | --- |
| Q2 2025 | Aug 14, 2025 | −$0.08 | −$0.11 | -37.50% | — | — |
| Q1 2025 | May 14, 2025 | −$0.10 | −$0.15 | -50.00% | — | — |
| Q4 2024 | Mar 27, 2025 | −$0.09 | $0.88 | 1114.99% | — | — |
| Q3 2024 | Nov 14, 2024 | −$0.48 | −$0.65 | -35.42% | — | — |
| Q2 2024 | Aug 14, 2024 | −$0.67 | −$0.66 | 1.49% | — | — |
| Q1 2024 | May 15, 2024 | −$0.79 | −$0.73 | 7.59% | — | — |
| Q4 2023 | Mar 27, 2024 | −$0.85 | −$0.64 | 24.71% | — | $501.00 |
| Q3 2023 | Nov 14, 2023 | −$1.12 | −$0.86 | 23.21% | — | $79,569.00 |
| Q2 2023 | Aug 14, 2023 | −$0.92 | −$1.11 | -20.65% | — | $116,410.00 |
| Q1 2023 | May 15, 2023 | −$0.87 | −$0.96 | -10.34% | — | $64,521.00 |
| Q4 2022 | Mar 31, 2023 | −$1.14 | −$1.08 | 5.26% | — | $53,440.00 |
| Q3 2022 | Nov 14, 2022 | −$1.08 | −$1.08 | 0.00% | $200,000.00 | $7,291.00 |
| Q2 2022 | Aug 12, 2022 | −$1.14 | −$1.08 | 5.26% | $300,000.00 | $6,552.00 |
| Q1 2022 | May 16, 2022 | −$1.02 | −$1.08 | -5.88% | $300,000.00 | $46,031.00 |
| Q4 2021 | Mar 31, 2022 | −$1.02 | −$1.14 | -11.76% | $300,000.00 | — |
| Q3 2021 | Nov 15, 2021 | −$0.84 | −$1.08 | -28.57% | $200,000.00 | $328,459.00 |

## Frequently Asked Questions

### When did Inhibikase (IKT) last report earnings?

Inhibikase last reported on Aug 14, 2025, covering fiscal Q2 2025.

### Did IKT beat earnings estimates?

No. Inhibikase reported EPS of −$0.11 for Q2 2025 against a −$0.08 estimate — a 37.50% miss.

---

Earnings figures may be restated, revised or corrected by the issuer. Past results do not indicate future performance.

This page is for informational purposes only. Nothing on it is a recommendation, solicitation or offer to buy or sell any security, nor investment, legal or tax advice. Light Horse Securities Inc does not verify third-party data and is not responsible for its accuracy, completeness or timeliness.

Data provided by [AInvest](https://www.ainvest.com).